Literature DB >> 7971980

The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.

J H Kordower1, S R Winn, Y T Liu, E J Mufson, J R Sladek, J P Hammang, E E Baetge, D F Emerich.   

Abstract

Six Rhesus monkeys between 24 and 29 years of age received unilateral transections of the fornix. Three monkeys then received intraventricular transplants of polymer-encapsulated baby hamster kidney (BHK) fibroblasts that had been genetically modified to secrete human nerve growth factor (hNGF). The remaining three monkeys received identical grafts except the cells were not modified to secrete hNGF. Monkeys receiving the fornix transection and control grafts displayed extensive reductions in the number of choline acetyltransferase- (57-75%) and p75 NGF receptor- (53%) immunoreactive medial septal neurons ipsilateral to the lesion/implant. In contrast, monkeys receiving transplants of encapsulated hNGF-secreting cells display only a modest loss of choline acetyltransferase- (0-36%) and p75 NGF receptor-(7-22.4%) immunoreactive septal neurons. Additionally, all monkeys receiving the hNGF-secreting implants, but none receiving control implants, displayed robust sprouting of cholinergic fibers within the septum ipsilateral to the transplant. Just prior to sacrifice, the capsules were retrieved and found to contain viable BHK cells releasing biologically relevant levels of hNGF. These data demonstrate that hNGF can provide trophic and tropic influences to aged primate basal forebrain neurons undergoing lesion-induced degeneration, supporting the contention that hNGF may prevent the degeneration of basal forebrain neurons in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971980      PMCID: PMC45133          DOI: 10.1073/pnas.91.23.10898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Response of the monkey cholinergic septohippocampal system to fornix transection: a histochemical and cytochemical analysis.

Authors:  J H Kordower; M S Fiandaca
Journal:  J Comp Neurol       Date:  1990-08-22       Impact factor: 3.215

2.  Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain.

Authors:  E J Mufson; M Bothwell; J H Kordower
Journal:  Exp Neurol       Date:  1989-09       Impact factor: 5.330

3.  Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

Authors:  L Olson; A Nordberg; H von Holst; L Bäckman; T Ebendal; I Alafuzoff; K Amberla; P Hartvig; A Herlitz; A Lilja
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1992

4.  Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability.

Authors:  S B Schueler; J D Ortega; J Sagen; J H Kordower
Journal:  J Neurosci       Date:  1993-10       Impact factor: 6.167

5.  Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates.

Authors:  V E Koliatsos; R E Clatterbuck; H J Nauta; B Knüsel; L E Burton; F F Hefti; W C Mobley; D L Price
Journal:  Ann Neurol       Date:  1991-12       Impact factor: 10.422

6.  Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.

Authors:  W C Benzing; M D Ikonomovic; D R Brady; E J Mufson; D M Armstrong
Journal:  J Comp Neurol       Date:  1993-08-08       Impact factor: 3.215

7.  Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF.

Authors:  D Hoffman; X O Breakefield; M P Short; P Aebischer
Journal:  Exp Neurol       Date:  1993-07       Impact factor: 5.330

8.  Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain.

Authors:  M H Tuszynski; H Sang; K Yoshida; F H Gage
Journal:  Ann Neurol       Date:  1991-11       Impact factor: 10.422

9.  Nerve growth factor (NGF) in the rat CNS: absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra.

Authors:  M E Schwab; U Otten; Y Agid; H Thoenen
Journal:  Brain Res       Date:  1979-06-08       Impact factor: 3.252

10.  Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons.

Authors:  S R Winn; J P Hammang; D F Emerich; A Lee; R D Palmiter; E E Baetge
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  40 in total

1.  Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation.

Authors:  J M Conner; M A Darracq; J Roberts; M H Tuszynski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 2.  Growth factor delivery for tissue engineering.

Authors:  J E Babensee; L V McIntire; A G Mikos
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

Review 3.  Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?

Authors:  Jeffrey H Kordower; C Warren Olanow
Journal:  Exp Neurol       Date:  2007-08-22       Impact factor: 5.330

4.  Molecular mechanisms regulating NGF-mediated enhancement of cholinergic neuronal phenotype: c-fos trans-activation of the choline acetyltransferase gene.

Authors:  J L Pongrac; R J Rylett
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

5.  Position-independent expression of a human nerve growth factor-luciferase reporter gene cloned on a yeast artificial chromosome vector.

Authors:  F A Asselbergs; R Grossenbacher; R Ortmann; B Hengerer; G K McMaster; E Sutter; R Widmer; F Buxton
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

Review 6.  Localized delivery of proteins in the brain: can transport be customized?

Authors:  M F Haller; W M Saltzman
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

7.  Gene transfer provides a practical means for safe, long-term, targeted delivery of biologically active neurotrophic factor proteins for neurodegenerative diseases.

Authors:  Christopher D Herzog; Kathie M Bishop; Lamar Brown; Alistair Wilson; Jeffrey H Kordower; Raymond T Bartus
Journal:  Drug Deliv Transl Res       Date:  2011-10       Impact factor: 4.617

Review 8.  Neurotrophins and the primate central nervous system: a minireview.

Authors:  M Hayashi
Journal:  Neurochem Res       Date:  1996-07       Impact factor: 3.996

9.  Plasma phospholipids identify antecedent memory impairment in older adults.

Authors:  Mark Mapstone; Amrita K Cheema; Massimo S Fiandaca; Xiaogang Zhong; Timothy R Mhyre; Linda H MacArthur; William J Hall; Susan G Fisher; Derick R Peterson; James M Haley; Michael D Nazar; Steven A Rich; Dan J Berlau; Carrie B Peltz; Ming T Tan; Claudia H Kawas; Howard J Federoff
Journal:  Nat Med       Date:  2014-03-09       Impact factor: 53.440

10.  TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin.

Authors:  T Sobreviela; D O Clary; L F Reichardt; M M Brandabur; J H Kordower; E J Mufson
Journal:  J Comp Neurol       Date:  1994-12-22       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.